XOMA.D

XOMA Royalty Corp

Healthcare · Biotechnology

$248.43 sample

+1.75 (+0.71%) 1D

Market cap

$1.55T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-08

Alerts

8

Price$248.43 +6.21% 3M daily closessample

256.73230.55

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 16INSInsider sell: Chief Financial Officer
Oct 08SECForm 144 filed
Sep 30INSInsider sell: Chief Executive Officer
Sep 23INSInsider sell: Director
Sep 15INSInsider sell: Chief Executive Officer
Sep 09SEC8-K filed: material event
Sep 04INSInsider buy: Chief Executive Officer
Aug 27SEC10-Q filed

Sign up to see the real XOMA.D record →

Company facts

SEC EDGAR registration

Name: XOMA Royalty Corp
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -23sample, -100 to +100
Reporting currency: USD

Who is positioning in XOMA.D

sample

Insiders: 10 insider transactions over 90 days, net selling, $68.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 20 funds hold $37.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$61.1B +12.8% y/y

Q4 2024Q3 2026

Inventory$36.1B +6.7% y/y

Q4 2024Q3 2026

Accounts receivable$27.5B +12.4% y/y

Q4 2024Q3 2026

Total debt$72.9B +7.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $264.1B +13.9% 3M
Sample peer B: $368.4B -9.7% 3M
Sample peer C: $1.07T +5.5% 3M
Sample peer D: $1.21T -2.1% 3M
Sample peer E: $917.8B -0.7% 3M